TransCode Therapeutics Inc (NASDAQ: RNAZ) is -89.42% lower on its value in year-to-date trading and has touched a low of $0.34 and a high of $66.33 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RNAZ stock was last observed hovering at around $0.40 in the last trading session, with the day’s loss setting it -0.04%.
Currently trading at $0.36, the stock is -32.35% and -89.41% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.36 million and changing -10.40% at the moment leaves the stock -96.52% off its SMA200. RNAZ registered -97.99% loss for a year compared to 6-month loss of -98.45%. The firm has a 50-day simple moving average (SMA 50) of $3.36668 and a 200-day simple moving average (SMA200) of $10.246795.
The stock witnessed a -56.23% gain in the last 1 month and extending the period to 3 months gives it a -88.82%, and is -6.53% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.10% over the week and 21.34% over the month.
Distance from 52-week low is 4.24% and -99.46% from its 52-week high. The company has generated returns on investments over the last 12 months (-903.45%).
The EPS is expected to grow by 96.54% this year
11.0 institutions hold shares in TransCode Therapeutics Inc (RNAZ), with institutional investors hold 0.67% of the company’s shares. The shares outstanding are 23.34M, and float is at 20.98M with Short Float at 12.17%. Institutions hold 0.67% of the Float.
